Starling Oncology Statistics
Total Valuation
STLN has a market cap or net worth of $356.97 million. The enterprise value is $422.84 million.
| Market Cap | 356.97M |
| Enterprise Value | 422.84M |
Important Dates
The last earnings date was Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
STLN has 101.99 million shares outstanding. The number of shares has increased by 19.64% in one year.
| Current Share Class | 101.99M |
| Shares Outstanding | 101.99M |
| Shares Change (YoY) | +19.64% |
| Shares Change (QoQ) | +1.65% |
| Owned by Insiders (%) | 10.03% |
| Owned by Institutions (%) | 49.53% |
| Float | 91.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| Forward PS | 0.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 18.96 |
| P/OCF Ratio | 15.45 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.68 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 22.46 |
Financial Position
The company has a current ratio of 1.11
| Current Ratio | 1.11 |
| Quick Ratio | 0.79 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | 5.46 |
| Interest Coverage | -2.02 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -7.48% |
| Return on Invested Capital (ROIC) | -28.53% |
| Return on Capital Employed (ROCE) | -32.80% |
| Weighted Average Cost of Capital (WACC) | 6.82% |
| Revenue Per Employee | $967,936 |
| Profits Per Employee | -$46,849 |
| Employee Count | 641 |
| Asset Turnover | 3.53 |
| Inventory Turnover | 18.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.48% in the last 52 weeks. The beta is 0.41, so STLN's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | +2.48% |
| 50-Day Moving Average | 6.23 |
| 200-Day Moving Average | 4.78 |
| Relative Strength Index (RSI) | 29.35 |
| Average Volume (20 Days) | 4,484,165 |
Short Selling Information
The latest short interest is 6.54 million, so 6.41% of the outstanding shares have been sold short.
| Short Interest | 6.54M |
| Short Previous Month | 6.79M |
| Short % of Shares Out | 6.41% |
| Short % of Float | 7.12% |
| Short Ratio (days to cover) | 4.75 |
Income Statement
In the last 12 months, STLN had revenue of $620.45 million and -$30.03 million in losses. Loss per share was -$0.29.
| Revenue | 620.45M |
| Gross Profit | 103.92M |
| Operating Income | -21.02M |
| Pretax Income | -35.54M |
| Net Income | -30.03M |
| EBITDA | -14.41M |
| EBIT | -21.02M |
| Loss Per Share | -$0.29 |
Balance Sheet
The company has $36.90 million in cash and $102.77 million in debt, with a net cash position of -$65.88 million or -$0.65 per share.
| Cash & Cash Equivalents | 36.90M |
| Total Debt | 102.77M |
| Net Cash | -65.88M |
| Net Cash Per Share | -$0.65 |
| Equity (Book Value) | -37.36M |
| Book Value Per Share | -0.37 |
| Working Capital | 13.99M |
Cash Flow
In the last 12 months, operating cash flow was $23.10 million and capital expenditures -$4.27 million, giving a free cash flow of $18.83 million.
| Operating Cash Flow | 23.10M |
| Capital Expenditures | -4.27M |
| Depreciation & Amortization | 6.61M |
| Net Borrowing | -7.01M |
| Free Cash Flow | 18.83M |
| FCF Per Share | $0.18 |
Margins
Gross margin is 16.75%, with operating and profit margins of -3.39% and -5.73%.
| Gross Margin | 16.75% |
| Operating Margin | -3.39% |
| Pretax Margin | -5.73% |
| Profit Margin | -5.73% |
| EBITDA Margin | -2.32% |
| EBIT Margin | -3.39% |
| FCF Margin | 3.03% |
Dividends & Yields
STLN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -19.64% |
| Shareholder Yield | -19.64% |
| Earnings Yield | -8.41% |
| FCF Yield | 5.27% |
Analyst Forecast
The average price target for STLN is $9.25, which is 164.29% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.25 |
| Price Target Difference | 164.29% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 32.28% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
STLN has an Altman Z-Score of 1.92 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.92 |
| Piotroski F-Score | 5 |